ObjectiveTo study the serum transforming growth factorβ1 (TGF-β1) and interleukin-23 (IL-23) expression in the patients with chronic gastric ulcer or gastric cancer, and to investigate the clinical value of TGF-β1 and IL-23 on the prevention and treatment of gastric cancer. MethodsThe serum levels of TGF-β1 and IL-23 in cancer group (83 cases), gastric ulcer group (184 cases), and control group (58 cases) were detected by using ELISA assay method. The difference of serum TGF-β1 and IL-23 levels in patients with gastric cancer with different pathological parameters were compared. ResultsThe serum levels of TGF-β1〔(15.96±3.92) ng/mL〕and IL-23〔(645.25±234.18) ng/mL〕in gastric cancer group were higher than those of the gastric ulcer group〔(10.10±3.58) ng/mL, (496.10±108.32) ng/mL〕and normal control group〔(9.87±2.86) ng/mL, (372.75±89.27) ng/mL〕, the difference were statistically significant (P < 0.05). The levels of serum TGF-β1 in gastric cancer patients of stageⅠ-Ⅱ, ⅢandⅣwere successively increased, and the differences were statistically significant (P < 0.05). The levels of serum TGF-β1 in poorly differentiated gastric cancer or with lymph node metastasis patients were higher than those in high-middle differentiation or without lymph node metastasis patients, the difference were statistically significant (P < 0.05). There were no significant difference in the levels of serum TGF-β1 between different tumor diameter and different location (P > 0.05). The level of serum IL-23 in patients with stageⅠ-Ⅱwas higher than that in stageⅢandⅣ, the difference was statistically significant (P < 0.05). Ther were no significant difference in serum IL-23 levels between the different degree of differentiation, lymph node metastasis or not, different tumor diameter and different location of the tumor (P > 0.05). ConclusionTGF-β1 and IL-23 have important reference value in judging the stage and malignancy degree of gastric cancer.
Objective To evaluate the effect of ultrasound guided percutaneous drainage on acute perforation of gastroduodenal ulcer in elderly patients. Methods The clinical features, treatments, and the curative effects of 86 elderly cases (≥65 years) of acute perforation of gastroduodenal ulcer in our hospital between January 2004 and October 2009 were retrospectively analyzed. Twenty-one cases were treated by ultrasound guided percutaneous drainage (drainage group), and 65 cases were treated by exploring operation (operation group). Results Drainage group was cured and had no complications. In 15 patients which accepted recheck one month after drainage, gastroscope showed the ulcer healed in 12 cases， and improved in 3 cases. In operation group, 63 cases were cured and 2 cases died. Compared with the drainage group, there was no significant difference in cure rate (Pgt;0.05). However, 11 patients had operative complications in operation group, which was significantly more than that in the drainage group （Plt;0.05）. In 45 patients which accepted recheck one month after operation, gastroscope showed the ulcer healed in 38 cases， and improved in 7 cases. Conclusion For elderly patients with acute perforation of gastroduodenal ulcer， if the patients do not fit for exploring operation， ultrasound guided percutaneous drainage is proved to be a simple, safe, and effective means.
目的 探讨康复新液联合奥美拉唑三联疗法治疗幽门螺杆菌（Hp）阳性的胃溃疡的临床疗效和内镜下溃疡愈合情况。 方法 将2010年1月－2012年1月对住院及门诊180例内镜诊断并检测证实Hp阳性的胃溃疡患者，按计算机产生的随机数字表随机分为两组，每组各90例。两组均给予口服奥美拉唑20 mg，2次/d，克拉霉素0.5 g，2次/d，甲硝唑0.4 g，2次/d，铝碳酸镁1.0 g，3次/d，治疗7 d。7 d后改为口服奥美拉唑20 mg，1次/d，铝碳酸镁1.0 g，3次/d，疗程4周，治疗组加服康复新液10 mL，3次/d；对照组不使用康复新液。治疗期间以上腹痛作为判断症状改善的主要指标，疗程结束后复查胃镜观察溃疡愈合情况，同时观察药物不良反应。 结果 治疗组在临床症状改善总有效率93.3%，对照组为总有效率82.2%；溃疡病灶愈合方面治疗组总有效率94.4%，对照组为总有效率83.3%，两组比较有统计学意义（P＜0.05），临床应用4周后无任何不良反应，Hp根除率两组间差异无统计学意义。 结论 康复新液联合奥美拉唑三联疗法可有效治疗胃溃疡，治疗期间患者未发生不良反应，为治疗胃溃疡的一种安全有效的药物。
目的 探讨预防胃大部切除术后碱性返流性胃炎的术式。方法 回顾性分析1998年6月至2008年12月期间我科收治的42例行胃大部切除术患者的临床资料，根据不同术式分为传统Billroth-Ⅱ（简称B-Ⅱ）式组（n=21）和改良B-Ⅱ式组（n=21），对2组患者术后胃肠引流液的量、剑突下持续烧灼痛、胆汁性呕吐、体重减轻以及肠胃液返流情况进行比较。结果 传统B-Ⅱ式组胃肠引流液量平均为（300±50） ml，而改良B-Ⅱ式组胃肠引流液量平均为（100±40） ml,2组间比较差异有统计学意义（P＜0.05）。传统B-Ⅱ式组剑突下持续烧灼痛12例，胆汁性呕吐8例，体重减轻1例； 而改良B-Ⅱ式组仅出现1例剑突下持续烧灼痛和1例体重减轻，未见胆汁性呕吐病例，2组间比较差异有统计学意义（P＜0.05）。传统B-Ⅱ式组发生轻度返流9例，重度返流12例; 改良B-Ⅱ式组仅2例发生轻度返流，1例重度返流，其余均未见返流，2组间比较差异有统计学意义（P＜0.05）。结论 与传统B-Ⅱ式相比，改良B-Ⅱ式的碱性返流性胃炎发生率明显降低，术后效果满意。
目的 探讨胃嗜酸性肉芽肿的诊断、误诊原因和治疗方法。方法 对14例胃嗜酸性肉芽肿的临床资料进行回顾性分析。结果 全部病例均有上腹疼痛和返酸史； 伴溃疡形成11例，穿孔4例，上消化道出血3例； 术前行胃镜检查2例，X线钡餐透视检查6例，无1例获确诊； 其余病例亦全部误诊为胃溃疡或癌肿。结论 胃镜多部位取材，特别是在溃疡与周边粘膜移行处，采取挖掘式取材，能减少误诊率； 胃大部切除术是主要的治疗方法。
摘要:目的:探讨量子血液疗法在胃溃疡治疗中的作用。方法:114例胃溃疡患者随机分为治疗组和对照组。治疗组60例,对照组54例。疗程均为4周。结果:经临床症状缓解,HP阴转及胃镜和病理复查的比较,治疗组总有效率99%,对照组总有效率为78%。经统计学处理,治疗组效果明显优于对照组(Plt;001)。结论:量子血液疗法对胃溃疡有肯定的辅助治疗作用。
目的：比较胃溃疡与溃疡型胃癌的发病特点。方法：对69例胃溃疡与32例胃癌进行回顾性分析，比较二者好发年龄、胃镜下变病部位和大小的差异。结果：63.7%胃溃疡多发生于50岁以下患者，81.3%胃癌发生于50岁以上患者（Ｐ＜0.01）。贲门部的胃癌是胃溃疡的5倍（Ｐ＜0.01）；胃角部的胃溃疡是胃癌的9倍（Ｐ＜0.01）；溃疡型胃癌与胃溃疡都易发生在胃窦，且检出率相似。82.6%胃溃疡直径＜3 cm，78.1%胃癌直径≥3 cm（Ｐ＜0.01）。结论：胃溃疡与溃疡型胃癌的好发年龄、生长部位和大小几乎各不相同，这些发病特点对溃疡型胃癌的早期诊断有一定指导意义。